Andy McElroy

Andy graduated from Churchill College Cambridge in 1980 with a first

class degree in Natural Sciences and completed a PhD in synthetic

organic chemistry before joining Glaxo as a medicinal chemist in 1983.

He spent seven years at the Ware and Greenford sites working on CNS targets and then three years at the Research Triangle Park in North Carolina as the lead chemist on Cardiovascular projects. Andy joined Pfizer in Sandwich in 1993 asa manager in the Medicinal Chemistry department and Therapeutic Area lead for Cardiovascular and Neurodegeneration Research and later on Tissue Repair managing a portfolio of projects up to First in Human. Andy then transitioned to the Pain therapeutic area as a research project leader and in 2009 became site lead at the Sandwich Site for External Research Solutions group, leading a multidisciplinary team focusing on optimising external research. In 2011, Andy established TRN-The Research Network Ltd, a new business model dedicated to enabling networked research, providing a flexible framework for the progression of drug discovery and development of novel therapeutic agents.